These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Longnecker R Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics. Orem J; Sandin S; Mbidde E; Mangen FW; Middeldorp J; Weiderpass E J Med Virol; 2014 Oct; 86(10):1796-803. PubMed ID: 24889739 [TBL] [Abstract][Full Text] [Related]
7. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients. Shapiro NL; Tang CG; Bhattacharyya N Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960 [TBL] [Abstract][Full Text] [Related]
8. [Atypical profile problem in serological diagnosis of EBV]. Varıcı Balcı FK; Özbek ÖA; Sayıner AA Mikrobiyol Bul; 2017 Oct; 51(4):378-386. PubMed ID: 29153068 [TBL] [Abstract][Full Text] [Related]
9. Quantitative PCR for Plasma Epstein-Barr Virus Loads in Cancer Diagnostics. Loghavi S Methods Mol Biol; 2016; 1392():51-61. PubMed ID: 26843046 [TBL] [Abstract][Full Text] [Related]
10. The role of Epstein-Barr virus in cancer. Pattle SB; Farrell PJ Expert Opin Biol Ther; 2006 Nov; 6(11):1193-205. PubMed ID: 17049016 [TBL] [Abstract][Full Text] [Related]
11. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211 [TBL] [Abstract][Full Text] [Related]
13. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus. Paludan C; Münz C Curr Mol Med; 2003 Jun; 3(4):341-7. PubMed ID: 12776989 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus--associated diseases in humans. Kawa K Int J Hematol; 2000 Feb; 71(2):108-17. PubMed ID: 10745621 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus: the first human tumor virus and its role in cancer. Pagano JS Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086 [TBL] [Abstract][Full Text] [Related]
18. A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease. Gan YJ; Razzouk BI; Su T; Sixbey JW Am J Pathol; 2002 Mar; 160(3):781-6. PubMed ID: 11891176 [TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients. Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]